New to Meducation?
Sign up
Already signed up? Log In

Resources

Category

Preview
0
0

Parental Catastrophizing Worsens Sickle Cell Disability

The effect isn't seen with protective parenting alone -- only when catastrophizing also occurs.  
medscape.com
over 3 years ago
Preview
0
1

EU agrees tighter standards for medical devices

The European Union has agreed major changes to its 20 year old regulatory framework for medical devices. These will introduce stricter rules and higher standards on the manufacture, authorisation, and sale of medical devices, ranging from sticking plasters and pacemakers to artificial hips and breast implants.  
feeds.bmj.com
over 3 years ago
Preview
0
7

Specialists attack drug agency’s fast track approval scheme

A plan to fast track the approval of new medicines in Europe has been criticised by a group of leading specialists in pharmacology and public health.  
feeds.bmj.com
over 3 years ago
Static.www.bmj
0
1

Seven days in medicine: 25-31 May

The total number of antibiotics prescribed by general practitioners in England fell 7.3% in one year—down from 37 million items in 2014-15 to 34.3 million in 2015-16, data from NHS Improvement showed. This significantly exceeds the 1% reduction target set by the national patient safety team with Public Health England and NHS England. GPs also managed to cut broad spectrum antibiotic prescribing by 16%, beating the 10% reduction target set for the NHS (full BMJ story at doi:10.1136/bmj.i3002).  
feeds.bmj.com
over 3 years ago
Preview
0
0

Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study

Objective To determine whether treatment with methylphenidate in children and young people with attention-deficit/hyperactivity disorder (ADHD) was associated with cardiovascular events.  
feeds.bmj.com
over 3 years ago
Preview
0
8

The cardiovascular safety of methylphenidate

In the United States alone, 6.4 million children received a diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2011. Of these, 3.5 million received a stimulant drug, typically methylphenidate.1 In addition, there is off label use of stimulants for milder attention problems. The cardiac safety of stimulants, which are known to slightly raise blood pressure and accelerate the heart rate, has been hotly debated as case reports,2 and conflicting evidence has emerged over time.3  
feeds.bmj.com
over 3 years ago
Preview
0
0

Migraine and risk of cardiovascular disease in women: prospective cohort study

Objective To evaluate the association between migraine and incident cardiovascular disease and cardiovascular mortality in women.  
feeds.bmj.com
over 3 years ago
Preview
0
9

Migraine and vascular disease

In the linked paper (doi:10.1136/bmj.i2610), Kurth and colleagues examine the link between migraine and cardiovascular events by using data from the Nurses’ Health Study II. The study followed a large cohort of female nurses for more than 20 years, 17 531 of whom reported a physician’s diagnosis of migraine at baseline. When compared with participants without migraine, those with migraine had an elevated risk of myocardial infarction, angina, or coronary revascularization and of cardiovascular mortality. Their relative risk for the combined outcome of all those events or stroke was roughly 50% higher than that for women without migraine, an effect that was not modified by age.1  
feeds.bmj.com
over 3 years ago
Preview
0
0

Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study

Objective To determine whether treatment with methylphenidate in children and young people with attention-deficit/hyperactivity disorder (ADHD) was associated with cardiovascular events.  
feeds.bmj.com
over 3 years ago
Preview
0
1

Migraine and risk of cardiovascular disease in women: prospective cohort study

Objective To evaluate the association between migraine and incident cardiovascular disease and cardiovascular mortality in women.  
feeds.bmj.com
over 3 years ago
Preview
0
8

The cardiovascular safety of methylphenidate

In the United States alone, 6.4 million children received a diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2011. Of these, 3.5 million received a stimulant drug, typically methylphenidate.1 In addition, there is off label use of stimulants for milder attention problems. The cardiac safety of stimulants, which are known to slightly raise blood pressure and accelerate the heart rate, has been hotly debated as case reports,2 and conflicting evidence has emerged over time.3  
feeds.bmj.com
over 3 years ago
Preview
0
7

Migraine and vascular disease

In the linked paper (doi:10.1136/bmj.i2610), Kurth and colleagues examine the link between migraine and cardiovascular events by using data from the Nurses’ Health Study II. The study followed a large cohort of female nurses for more than 20 years, 17 531 of whom reported a physician’s diagnosis of migraine at baseline. When compared with participants without migraine, those with migraine had an elevated risk of myocardial infarction, angina, or coronary revascularization and of cardiovascular mortality. Their relative risk for the combined outcome of all those events or stroke was roughly 50% higher than that for women without migraine, an effect that was not modified by age.1  
feeds.bmj.com
over 3 years ago
Preview
0
0

Sixty seconds on . . . Tamiflu

Yes, indeed. A new Cochrane analysis has found insufficient evidence to show that it saved lives in the 2009 H1N1 flu epidemic.1  
feeds.bmj.com
over 3 years ago
Preview
0
6

Bariatric surgery for obese adolescents to prevent type 2 diabetes

Welbourn and colleagues draw attention to the inequality of surgical provision between the United Kingdom and comparable nations in Europe and North America,1 and the failure to target subgroups with the greatest potential for individual benefit and cost utility to the healthcare system, such as patients with type 2 diabetes.  
feeds.bmj.com
over 3 years ago
Preview
0
6

Radiology Board Plans to Drop 10-Year MOC Exam

It is evaluating a revision that will involve a less burdensome program with ongoing questions to test radiologists knowledge. The decision follows an ABIM report calling for similar approach.  
medscape.com
over 3 years ago
Preview
0
0

Sixty seconds on . . . Tamiflu

Yes, indeed. A new Cochrane analysis has found insufficient evidence to show that it saved lives in the 2009 H1N1 flu epidemic.1  
feeds.bmj.com
over 3 years ago
Preview
0
7

Migraine and vascular disease

In the linked paper (doi:10.1136/bmj.i2610), Kurth and colleagues examine the link between migraine and cardiovascular events by using data from the Nurses’ Health Study II. The study followed a large cohort of female nurses for more than 20 years, 17 531 of whom reported a physician’s diagnosis of migraine at baseline. When compared with participants without migraine, those with migraine had an elevated risk of myocardial infarction, angina, or coronary revascularization and of cardiovascular mortality. Their relative risk for the combined outcome of all those events or stroke was roughly 50% higher than that for women without migraine, an effect that was not modified by age.1  
feeds.bmj.com
over 3 years ago
Preview
0
1

EU agrees tighter standards for medical devices

The European Union has agreed major changes to its 20 year old regulatory framework for medical devices. These will introduce stricter rules and higher standards on the manufacture, authorisation, and sale of medical devices, ranging from sticking plasters and pacemakers to artificial hips and breast implants.  
feeds.bmj.com
over 3 years ago
Preview
0
0

European drug agency recommends limiting colistin use in animals to cut resistance in patients

The European Medicines Agency (EMA) has recommended limiting sales of colistin for use in animals, in new guidance that aims to halt the spread of resistance in patients who receive it as the antibiotic of last resort for multidrug resistant bacterial infections.1  
feeds.bmj.com
over 3 years ago
Preview
0
6

WHO to set up emergencies programme

The World Health Organization will establish a health emergencies programme in response to widespread criticism over its handling of the Ebola epidemic in west Africa.1 WHO described the programme as one of the most “profound transformations” in its history. The organisation would take an operational role in emergencies, as well as its usual technical role.  
feeds.bmj.com
over 3 years ago